Comparative Effectiveness and Safety of Oral Anticoagulants across Kidney Function in Patients with Atrial Fibrillation

BACKGROUND: Patients with atrial fibrillation (AF) and severely decreased kidney function were excluded from the pivotal NOAC trials, thereby raising questions about comparative safety and effectiveness in patients with reduced kidney function. The study aimed to compare oral anticoagulants across t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Circ Cardiovasc Qual Outcomes
Autori principali: Yao, Xiaoxi, Inselman, Jonathan W., Ross, Joseph S., Izem, Rima, Graham, David J., Martin, David B., Thompson, Aliza M., Southworth, Mary Ross, Siontis, Konstantinos C., Ngufor, Che G., Nath, Karl A., Desai, Nihar R., Nallamothu, Brahmajee K., Saran, Rajiv, Shah, Nilay D., Noseworthy, Peter A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7580213/
https://ncbi.nlm.nih.gov/pubmed/33012172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.120.006515
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi